OrthoPediatrics Raises FY2026 Sales Guidance from $265.000M-$269.000M to $270.000M-$273.000M vs $266.983M Est
Benzinga Newsdesk 3 weeks ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $265.000 million-$269.000 million to $270.000 million-$273.000 million vs $266.983 million estimate.
OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $265.000 million-$269.000 million to $270.000 million-$273.000 million vs $266.983 million estimate.
